Since inception, NovImmune has raised a total of CHF 154 million CHF in 4 major rounds of financing.

Our main investors are:

• BZ Bank
• Novartis Venture Fund
• Ingro Finanz
• Varuma
• Pictet Private Equity Fund
• Aravis Venture Fund